More than 300,000 children and youth in Ontario have
one or more neurodevelopment disorders.
At POND, we are here to address the clear and urgent need for new and
better targeted therapies in an effort to improve the long-term outcomes
for children with ASD, ADHD, OCD, ID, Rett Syndrome, Tourette Syndrome,
Fragile X Syndrome, and Down Syndrome.